{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:18:23Z","timestamp":1790839103331,"version":"4.1.0"},"reference-count":23,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>This study aimed to extract and analyze comprehensive data from the National Cancer Database (NCDB) to gain insights into the epidemiological prevalence, treatment patterns, and survival outcomes associated with intracranial ependymomas in pediatric patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>The authors examined data extracted from the NCDB spanning the years 2010 to 2017, with a specific emphasis on intracranial ependymomas in individuals aged 0\u201321 years. The study used logistic and Poisson regression, along with Kaplan-Meier survival estimates and Cox proportional hazards models, for analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Among 908 included pediatric patients, 495 (54.5%) were male, and 702 (80.6%) were White. Kaplan-Meier analysis determined overall survival (OS) rates of 97.1% (95% CI 96%\u201398.2%) at 1 year postdiagnosis, 89% (95% CI 86.9%\u201391.1%) at 3 years, 82.9% (95% CI 80.3%\u201385.7%) at 5 years, and 74.5% (95% CI 69.8%\u201379.4%) at 10 years. Grade 3 tumors predicted a more than fourfold higher mortality hazard (p &lt; 0.001; reference = grade 2). Infratentorial localization was also associated with a 1.7-fold increase in mortality hazard (p = 0.002; reference = supratentorial). Larger maximum tumor size (&gt; 5 cm) correlated with a lower mortality hazard (HR 0.64, p = 0.011; reference \u2264 5 cm). The vast majority of patients (85.9%, n = 780) underwent resection. Uninsured patients had over fourfold higher prolonged length of stay (LOS) odds than those privately insured (OR 4.645, p = 0.007). Radiotherapy was received by 76.1% of patients, and the highest rates of radiotherapy occurred among children aged 5\u201312 years (p &lt; 0.001). Only 25.6% received chemotherapy at any point during their treatment. Peak chemotherapy use emerged within ages 0\u20134 years, reaching 33.6% in this age group. Kaplan-Meier analysis indicated chemotherapy was associated with significantly worse OS (p = 0.041).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>This comprehensive analysis of the NCDB provides valuable insights into the epidemiology, treatment patterns, and survival outcomes of intracranial ependymomas in pediatric patients. Higher tumor grade, infratentorial localization, and chemotherapy use was associated with worse OS, while larger tumor size correlated with lower mortality hazard. Disparities in care were identified, with uninsured patients experiencing prolonged LOS. These findings underscore the need for tailored treatment strategies based on patient and tumor characteristics and highlight the importance of addressing socioeconomic barriers to optimize outcomes for children with ependymomas.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2024.5.peds2480","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T02:29:47Z","timestamp":1723256987000},"page":"495-508","source":"Crossref","is-referenced-by-count":4,"title":["Intracranial ependymomas in pediatric patients: patterns of care, disparities, and survival outcomes from the National Cancer Database"],"prefix":"10.3171","volume":"34","author":[{"given":"Pemla","family":"Jagtiani","sequence":"first","affiliation":[{"name":"School of Medicine, SUNY Downstate Health Sciences University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"Karabacak","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mount Sinai Health System; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Le","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mount Sinai Health System; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Bahadir","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Morgenstern","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mount Sinai Health System; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Margetis","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mount Sinai Health System; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"1","key":"b1","series-title":"Neurooncol Adv","first-page":"vdaa019","article-title":"Comparison of epidemiology, treatments, and outcomes in pediatric versus adult ependymoma","volume":"2","author":"Elsamadicy AA","year":"2020","unstructured":"Elsamadicy AA, Koo AB, David WB,  Comparison of epidemiology, treatments, and outcomes in pediatric versus adult ependymoma. Neurooncol Adv. 2020;2(1):vdaa019."},{"issue":"8","key":"b2","series-title":"Childs Nerv Syst","first-page":"2451","article-title":"Pediatric ependymoma: an overview of a complex disease","volume":"37","author":"J\u00fcnger ST","year":"2021","unstructured":"J\u00fcnger ST, Timmermann B, Pietsch T. Pediatric ependymoma: an overview of a complex disease. Childs Nerv Syst. 2021;37(8):2451\u20132463."},{"issue":"5","key":"b3","series-title":"Cancer Cell","first-page":"728","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler KW","year":"2015","unstructured":"Pajtler KW, Witt H, Sill M,  Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27(5):728\u2013743."},{"issue":"1","key":"b4","series-title":"Mod Pathol","first-page":"47","article-title":"Characterization of molecular signatures of supratentorial ependymomas","volume":"33","author":"Torre M","year":"2020","unstructured":"Torre M, Alexandrescu S, Dubuc AM, Ligon AH, Hornick JL, Meredith DM. Characterization of molecular signatures of supratentorial ependymomas. Mod Pathol. 2020;33(1):47\u201356."},{"issue":"9","key":"b5","series-title":"JAMA Surg","first-page":"850","article-title":"Practical guide to surgical data sets: National Cancer Database (NCDB)","volume":"153","author":"Merkow RP","year":"2018","unstructured":"Merkow RP, Rademaker AW, Bilimoria KY. Practical guide to surgical data sets: National Cancer Database (NCDB). JAMA Surg. 2018;153(9):850\u2013851."},{"issue":"9596","key":"b6","series-title":"Lancet","first-page":"1453","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20131457."},{"issue":"3","key":"b7","series-title":"Neurosurg Focus","first-page":"E4","article-title":"Intracranial ependymoma","volume":"13","author":"Maksoud YA","year":"2002","unstructured":"Maksoud YA, Hahn YS, Engelhard HH. Intracranial ependymoma. Neurosurg Focus. 2002;13(3):E4."},{"issue":"4","key":"b8","series-title":"Neurooncol Pract","first-page":"391","article-title":"The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymoma","volume":"7","author":"Prabhu RS","year":"2020","unstructured":"Prabhu RS, Corso CD, Ward MC,  The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymoma. Neurooncol Pract. 2020;7(4):391\u2013399."},{"issue":"2","key":"b9","series-title":"Oman Med J","first-page":"e122","article-title":"Implications of language barriers for healthcare: a systematic review","volume":"35","author":"Al Shamsi H","year":"2020","unstructured":"Al Shamsi H, Almutairi AG, Al Mashrafi S, Al Kalbani T. Implications of language barriers for healthcare: a systematic review. Oman Med J. 2020;35(2):e122."},{"issue":"12","key":"b10","series-title":"Acad Med","first-page":"1139","article-title":"Health disparities based on socioeconomic inequities: implications for urban health care","volume":"79","author":"Fiscella K","year":"2004","unstructured":"Fiscella K, Williams DR. Health disparities based on socioeconomic inequities: implications for urban health care. Acad Med. 2004;79(12):1139\u20131147."},{"issue":"23","key":"b11","series-title":"Cancers (Basel)","first-page":"6128","article-title":"An overview of intracranial ependymomas in adults","volume":"13","author":"Lombardi G","year":"2021","unstructured":"Lombardi G, Della Puppa A, Pizzi M,  An overview of intracranial ependymomas in adults. Cancers (Basel). 2021;13(23):6128."},{"issue":"12","key":"b12","series-title":"J Clin Neurosci","first-page":"2096","article-title":"Prognosis by tumor location in adults with intracranial ependymomas","volume":"21","author":"Sayegh ET","year":"2014","unstructured":"Sayegh ET, Aranda D, Kim JM, Oh T, Parsa AT, Oh MC. Prognosis by tumor location in adults with intracranial ependymomas. J Clin Neurosci. 2014;21(12):2096\u20132101."},{"issue":"2","key":"b13","series-title":"J Neurosurg","first-page":"525","article-title":"Resection and radiotherapy for intracranial ependymoma: a multiinstitutional 50-year experience","volume":"137","author":"Zuccato JA","year":"2021","unstructured":"Zuccato JA, Algan O, Nair VJ,  Resection and radiotherapy for intracranial ependymoma: a multiinstitutional 50-year experience. J Neurosurg. 2021;137(2):525\u2013532."},{"issue":"1","key":"b14","series-title":"Semin Radiat Oncol","first-page":"21","article-title":"Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other","volume":"20","author":"Krasin MJ","year":"2010","unstructured":"Krasin MJ, Constine LS, Friedman DL, Marks LB. Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other. Semin Radiat Oncol. 2010;20(1):21\u201329."},{"issue":"8","key":"b15","series-title":"Curr Oncol Rep","first-page":"985","article-title":"Ependymoma: evaluation and management updates","volume":"24","author":"Rud\u00e0 R","year":"2022","unstructured":"Rud\u00e0 R, Bruno F, Pellerino A, Soffietti R. Ependymoma: evaluation and management updates. Curr Oncol Rep. 2022;24(8):985\u2013993."},{"issue":"2","key":"b16","series-title":"Pediatr Hematol Oncol J","first-page":"114","article-title":"Pediatric ependymomas: something old, something new","volume":"8","author":"Korones DN","year":"2023","unstructured":"Korones DN. Pediatric ependymomas: something old, something new. Pediatr Hematol Oncol J. 2023;8(2):114\u2013120."},{"issue":"5","key":"b17","series-title":"Brain Pathol","first-page":"584","article-title":"Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system","volume":"23","author":"Raghunathan A","year":"2013","unstructured":"Raghunathan A, Wani K, Armstrong TS,  Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol. 2013;23(5):584\u2013594."},{"issue":"7306","key":"b18","series-title":"Nature","first-page":"632","article-title":"Cross-species genomics matches driver mutations and cell compartments to model ependymoma","volume":"466","author":"Johnson RA","year":"2010","unstructured":"Johnson RA, Wright KD, Poppleton H,  Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature. 2010;466(7306):632\u2013636."},{"issue":"5","key":"b19","series-title":"Acta Neuropathol","first-page":"727","article-title":"A prognostic gene expression signature in infratentorial ependymoma","volume":"123","author":"Wani K","year":"2012","unstructured":"Wani K, Armstrong TS, Vera-Bolanos E,  A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol. 2012;123(5):727\u2013738."},{"issue":"2","key":"b20","series-title":"Cancer Cell","first-page":"143","article-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","volume":"20","author":"Witt H","year":"2011","unstructured":"Witt H, Mack SC, Ryzhova M,  Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell. 2011;20(2):143\u2013157."},{"issue":"7489","key":"b21","series-title":"Nature","first-page":"451","article-title":"C11orf95-RELA fusions drive oncogenic NF-\u03baB signalling in ependymoma","volume":"506","author":"Parker M","year":"2014","unstructured":"Parker M, Mohankumar KM, Punchihewa C,  C11orf95-RELA fusions drive oncogenic NF-\u03baB signalling in ependymoma. Nature. 2014;506(7489):451\u2013455."},{"issue":"7","key":"b22","series-title":"Neuro Oncol","first-page":"902","article-title":"Biology and management of ependymomas","volume":"18","author":"Wu J","year":"2016","unstructured":"Wu J, Armstrong TS, Gilbert MR. Biology and management of ependymomas. Neuro Oncol. 2016;18(7):902\u2013913."},{"issue":"10","key":"b23","series-title":"Clin Cancer Res","first-page":"3054","article-title":"ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease","volume":"8","author":"Gilbertson RJ","year":"2002","unstructured":"Gilbertson RJ, Bentley L, Hernan R,  ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res. 2002;8(10):3054\u20133064."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/34\/5\/article-p495.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/34\/5\/article-p495.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/34\/5\/article-p495.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T13:08:50Z","timestamp":1733490530000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/34\/5\/article-p495.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":23,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2024.5.peds2480","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}